Gladstone Institutional Advisory’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$430K Buy
+5,079
New +$410K 0.01% 642
2026
Q1
Sell
-2,564
Closed -$202K 868
2025
Q4
$202K Buy
+2,564
New +$203K 0.01% 761
2022
Q3
Sell
-9,684
Closed -$608K 661
2022
Q2
$608K Buy
+9,684
New +$641K 0.05% 365
2021
Q3
Sell
-14,214
Closed -$851K 579
2021
Q2
$851K Buy
14,214
+596
+4% +$37.8K 0.1% 212
2021
Q1
$828K Buy
+13,618
New +$752K 0.13% 167

Other funds holding MET

Gladstone Institutional Advisory's MET Position: Q2 2026 in Review

Gladstone Institutional Advisory opened a new position in MetLife (MET) in Q2 2026: 5,079 shares worth $430K. The stake represents 0.01% of the portfolio and ranks #642 among its holdings. This is a return to the name: Gladstone Institutional Advisory previously reported a position in MET as recently as Q4 2025.

Gladstone Institutional Advisory first reported a position in MET in Q1 2021 and has held it in 5 quarters since. The position peaked at $851K in Q2 2021. 1,448 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Gladstone Institutional Advisory held 5,079 shares of MetLife worth $430K as of Q2 2026.
  • MetLife was a new Gladstone Institutional Advisory position in Q2 2026.
  • MetLife made up 0.01% of Gladstone Institutional Advisory's portfolio in Q2 2026, its #642 holding.
  • Gladstone Institutional Advisory first reported a position in MetLife in Q1 2021 and has held it in 5 quarters since.
  • Gladstone Institutional Advisory's MetLife position peaked at $851K in Q2 2021.
  • 1,448 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.